In gastric cancer surgery, what is the minimum extent of lymphadenectomy (D classification) recommended as the standard of care for curative intent gastrectomy?

Explanation

## Lymphadenectomy Extent in Gastric Cancer Surgery **Key Point:** D2 lymphadenectomy (perigastric and regional lymph nodes) is the **gold standard and minimum recommended extent** for curative intent gastrectomy in gastric cancer, as per Japanese Gastric Cancer Association and international guidelines. ### Japanese D-Classification System | D Level | Lymph Node Groups | Indication | Prognosis Impact | |---------|-------------------|-----------|------------------| | D0 | None | Palliative/non-curative | Poor | | D1 | Perigastric (N1) only | Inadequate for curative intent | Suboptimal | | D2 | Perigastric + regional (N1, N2) | **Standard curative intent** | Optimal | | D3 | D2 + para-aortic (N3) | Selected cases with N2+ disease | Controversial | ### Lymph Node Station Definitions **Perigastric (N1):** Stations 1–6 (along lesser curve, greater curve, superior/inferior gastric vessels) **Regional (N2):** Stations 7–11 (left gastric, splenic, celiac, superior mesenteric artery nodes) **Extended (N3):** Stations 12–16 (hepatic, retropancreatic, para-aortic nodes) **High-Yield:** The **MAGIC trial** (2009) and **Dutch D2 trial** (1999) demonstrated that D2 lymphadenectomy, when performed by experienced surgeons, improves long-term survival and is associated with acceptable morbidity in curative-intent gastrectomy. ### Clinical Application - **D2 is mandatory** for stages IB–III gastric cancer - **D1+ (extended perigastric)** may be acceptable for very early T1a N0 cancers - **D3 (para-aortic dissection)** is not routinely recommended due to increased morbidity without proven survival benefit - **Splenectomy and distal pancreatectomy** are often required to achieve adequate D2 dissection (stations 10, 11) **Clinical Pearl:** Inadequate lymphadenectomy (D0 or D1) is a major cause of understaging and poor long-term outcomes; it is considered a violation of oncologic principles in curative-intent surgery. **Warning:** D3 lymphadenectomy is associated with increased operative mortality and morbidity without clear survival advantage in randomized trials; it is not standard practice. [cite:Japanese Gastric Cancer Association Guidelines, Harrison 21e Ch 297]